Matthew B.B. Yurgelun
Brigham and Women's Hospital · 474 works · 7,791 citations · h-index 41
Top works
- Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
- NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 1.2020
- Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer
- Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine
- Identification of a Variety of Mutations in Cancer Predisposition Genes in Patients With Suspected Lynch Syndrome
- NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2024
- Evaluating Susceptibility to Pancreatic Cancer: ASCO Provisional Clinical Opinion
- Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next-Generation Sequencing
- Germline cancer susceptibility gene variants, somatic second hits, and survival outcomes in patients with resected pancreatic cancer
- Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome
- Effect of High-Dose vs Standard-Dose Vitamin D3 Supplementation on Progression-Free Survival Among Patients With Advanced or Metastatic Colorectal Cancer
- Recruitment of osteoclast precursors by stromal cell derived factor‐1 (SDF‐1) in giant cell tumor of bone
- Delphi Initiative for Early-Onset Colorectal Cancer (DIRECt) International Management Guidelines
- Recent progress in Lynch syndrome and other familial colorectal cancer syndromes
- NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021.
- GermlineTP53Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry
- Precision Prevention and Early Detection of Cancer: Fundamental Principles
- Recent advances in Lynch syndrome
- Combined PD-1, BRAF and MEK inhibition in BRAFV600E colorectal cancer: a phase 2 trial
- Microsatellite Instability and DNA Mismatch Repair Protein Deficiency in Lynch Syndrome Colorectal Polyps